| Computation of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders |
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
1,935 |
|
|
$ |
(11,597 |
) |
|
$ |
(8,638 |
) |
|
$ |
(53,110 |
) |
Net income (loss) attributable to noncontrolling interest |
|
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
(1 |
) |
Net income (loss) attributable to common stockholders |
|
$ |
1,935 |
|
|
$ |
(11,597 |
) |
|
$ |
(8,645 |
) |
|
$ |
(53,109 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares outstanding used to compute net income (loss) per share attributable to common stockholders, basic |
|
|
57,333,901 |
|
|
|
50,920,588 |
|
|
|
54,508,819 |
|
|
|
50,653,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock based awards |
|
|
3,108,687 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Shares reserved for charitable contribution |
|
|
20,131 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Weighted-average number of shares outstanding used to compute net income (loss) per share attributable to common stockholders, diluted |
|
|
60,462,719 |
|
|
|
50,920,588 |
|
|
|
54,508,819 |
|
|
|
50,653,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share, basic |
|
$ |
0.03 |
|
|
$ |
(0.23 |
) |
|
$ |
(0.16 |
) |
|
$ |
(1.05 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share, diluted |
|
$ |
0.03 |
|
|
$ |
(0.23 |
) |
|
$ |
(0.16 |
) |
|
$ |
(1.05 |
) |
|
| Schedule of Outstanding Shares of Potentially Dilutive Securities Excluded from Computation of Diluted Net Income (Loss) Per Share |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net income (loss) per share because including them would have had an anti-dilutive effect, or issuance of such shares is contingent upon the occurrence of an event:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Stock based awards |
|
|
2,786 |
|
|
|
5,063,656 |
|
|
|
4,187,499 |
|
|
|
5,063,656 |
|
Shares reserved for charitable contribution |
|
|
— |
|
|
|
100,663 |
|
|
|
20,131 |
|
|
|
100,663 |
|
2027 Notes |
|
|
1,528,009 |
|
|
|
1,529,157 |
|
|
|
1,528,770 |
|
|
|
1,529,157 |
|
2030 Notes |
|
|
5,312,375 |
|
|
|
5,312,375 |
|
|
|
5,312,375 |
|
|
|
5,312,375 |
|
Total shares |
|
|
6,843,170 |
|
|
|
12,005,851 |
|
|
|
11,048,775 |
|
|
|
12,005,851 |
|
|